Literature DB >> 20207018

The hypothalamic endocannabinoid system participates in the secretion of oxytocin and tumor necrosis factor-alpha induced by lipopolysaccharide.

Andrea De Laurentiis1, Javier Fernandez-Solari, Claudia Mohn, Berenice Burdet, María A Zorrilla Zubilete, Valeria Rettori.   

Abstract

This study investigated the participation of the hypothalamic endocannabinoid system in the response to lipopolysaccharide (LPS) challenge evaluating oxytocin (OXT) and tumor necrosis factor-alpha (TNF-alpha) plasma levels in vivo and their release from hypothalamic fragments in vitro. LPS increased OXT and TNF-alpha release through anandamide-activation of hypothalamic cannabinoid receptor CB(1,) since the antagonist AM251 blocked this effect. Anandamide, through its receptors, also increased hypothalamic nitric oxide (NO) which inhibited OXT release, ending the stimulatory effect of the endocannabinoid. Our findings reveal a hypothalamic interaction between oxytocin, endocannabinoid and NO-ergic systems providing a regulation of the hypothalamic-neurohypophyseal axis under basal and stress conditions. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20207018     DOI: 10.1016/j.jneuroim.2010.02.006

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Severe hyponatraemia during sepsis and marijuana addiction.

Authors:  Concetta Catalano; Sidy Seck; Giuseppe Enia
Journal:  BMJ Case Rep       Date:  2011-03-29

Review 2.  Endocannabinoids and the Endocrine System in Health and Disease.

Authors:  Cecilia J Hillard
Journal:  Handb Exp Pharmacol       Date:  2015

3.  The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.

Authors:  Alexandre A Steiner; Alla Y Molchanova; M Devrim Dogan; Shreya Patel; Erika Pétervári; Márta Balaskó; Samuel P Wanner; Justin Eales; Daniela L Oliveira; Narender R Gavva; M Camila Almeida; Miklós Székely; Andrej A Romanovsky
Journal:  J Physiol       Date:  2011-03-14       Impact factor: 5.182

Review 4.  Stress, alcohol and infection during early development: A brief review of common outcomes and mechanisms.

Authors:  P N Surkin; H Brenhouse; T Deak; A C Liberman; M Lasaga
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

5.  Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray.

Authors:  A R Wilson-Poe; M M Morgan; S A Aicher; D M Hegarty
Journal:  Neuroscience       Date:  2012-04-19       Impact factor: 3.590

6.  Immune stress in late pregnant rats decreases length of gestation and fecundity, and alters later cognitive and affective behaviour of surviving pre-adolescent offspring.

Authors:  Jason J Paris; Paula J Brunton; John A Russell; Cheryl A Frye
Journal:  Stress       Date:  2011-11       Impact factor: 3.493

7.  The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids.

Authors:  Adrianne R Wilson-Poe; Edvinas Pocius; Melissa Herschbach; Michael M Morgan
Journal:  Pharmacol Biochem Behav       Date:  2012-10-10       Impact factor: 3.533

8.  Brain CB₁ receptor expression following lipopolysaccharide-induced inflammation.

Authors:  H Hu; W Ho; K Mackie; Q J Pittman; K A Sharkey
Journal:  Neuroscience       Date:  2012-10-04       Impact factor: 3.590

9.  Differential Expression of CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Protein 1a in Labor.

Authors:  Melissa L Kozakiewicz; Jie Zhang; Sandra Leone-Kabler; Liliya M Yamaleyeva; Anna G McDonald; Brian C Brost; Allyn C Howlett
Journal:  Cannabis Cannabinoid Res       Date:  2021-04-16

10.  Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic Rats.

Authors:  Abdulrahman L Al-Malki
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.